HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Repka, M. X. Search for Related Content

The Pediatric Eye Disease Investigator Group

Correspondence: Requests for reprints should be addressed to: Michael X. Repka, M.D., Johns Hopkins University, Wilmer Eye Institute, 600 N. Wolfe St., Wilmer 233, Baltimore, MD 21287-9028; e-mail:mrepka{at}jhmi.edu.

Introduction and Background: The Pediatric Eye Disease Investigator Group is a network of pediatric eye care providers undertaking clinical trials with National Eye Institute support. The network includes university- and community-based providers.

Methods: Randomized and observation studies have involved refining the best amblyopia treatment in children from 3 to less than 18 years of age, observation of the behavior of early-onset esotropia, treatment of primary congenital nasolacrimal duct obstruction, and observation of the stability of strabismic angle in esotropia.

Conclusions: To date 16 studies have been undertaken enrolling 5064 children and teens.

Key words: PEDIG, amblyopia treatment, clinical trials